Unlocking the Power of Clean Energy: Ivanhoe Electric’s VRB Energy Subsidiary Secures $55 Million Investment

Exciting News for Ivanhoe Electric and VRB Energy Phoenix, Arizona–(Newsfile Corp. – September 23, 2024) – It is with great pleasure that Ivanhoe Electric Inc. announces a significant development for its subsidiary, VRB Energy Inc. A binding Term Sheet has been executed with a subsidiary of Shanxi Red Sun Co., Ltd. (“Red Sun”) which will…

Read More

XOMA Royalty Announces Quarterly Dividends for Preferred Stock

XOMA Royalty Corporation Announces Dividend Declaration Emeryville, Calif., September 23, 2024 XOMA Royalty Corporation (Nasdaq: XOMA) has made an exciting announcement today regarding cash dividends for holders of XOMA’s Series A and Series B Cumulative Preferred Stock. Details of Dividend Declaration: The Board of Directors has authorized the following cash dividends: Holders of the 8.625%…

Read More

Score! Neotech Metals Corp. Gets the Green Light for $200K Grant in Ontario Exploration Program

Exploring Ontario’s Mineral Resources with Neotech Metals Corp. Discovering the Green Transition, One Grant at a Time Hold onto your hockey sticks, maple syrup lovers! Neotech Metals Corp. is making waves in the exploration world with their recent approval by the Ontario Junior Exploration Program (OJEP). This exciting news means that Neotech will receive $200,000…

Read More

Nasdaq Expands Digital Bank and FinTech Presence in Latin America

Expanded Partnership with Nubank Reflects Rapid Growth of Banking and Payment Services in Latin America Introduction Over half of Nasdaq’s Latin American banking clients have expanded their technology partnership in the last 12 months. Nasdaq’s financial technology solutions simplify regulatory compliance and reduce time to market across multiple jurisdictions. New Partnership with Nubank New York…

Read More

Clever Collaboration: Nicox and Glaukos Join Forces for NCX-1728 Research and Global Licensing

Nicox and Glaukos sign exclusive research and licensing agreement Clever, personable, and wonderfully unconventional, yet reader-friendly, the recent agreement between Nicox and Glaukos has created quite a stir in the world of ophthalmology. The two companies have signed an exclusive research and license option agreement for NCX 1728, Nicox’s novel nitric oxide-donating phosphodiesterase-5 inhibitor. What…

Read More

Breaking News: FDA Clears Innate Pharma’s IND for IPH4502, a Promising Treatment for Solid Tumors

Exciting Development in Cancer Treatment: Innate Pharma Receives FDA Clearance for Phase 1 Study Marseille, France (BUSINESS WIRE) Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) announced today that the U.S Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to initiate a Phase 1 clinical study of IPH4502, its novel…

Read More